-
1
-
-
84896735708
-
Signaling cross-talk in the resistance to HER family receptor targeted therapy
-
23542173
-
Yamaguchi H, Chang SS, Hsu JL, Hung MC. Signaling cross-talk in the resistance to HER family receptor targeted therapy. Oncogene 2014, 33(9):1073-81. 10.1038/onc.2013.74, 23542173.
-
(2014)
Oncogene
, vol.33
, Issue.9
, pp. 1073-1081
-
-
Yamaguchi, H.1
Chang, S.S.2
Hsu, J.L.3
Hung, M.C.4
-
2
-
-
84859355565
-
Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy
-
22474259
-
Logue JS, Morrison DK. Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy. Genes Dev 2012, 26(7):641-50. 10.1101/gad.186965.112, 22474259.
-
(2012)
Genes Dev
, vol.26
, Issue.7
, pp. 641-650
-
-
Logue, J.S.1
Morrison, D.K.2
-
3
-
-
69949151386
-
Factors underlying sensitivity of cancers to small-molecule kinase inhibitors
-
19629074
-
Jänne PA, Gray N, Settleman J. Factors underlying sensitivity of cancers to small-molecule kinase inhibitors. Nat Rev Drug Discov 2009, 8(9):709-23. 10.1038/nrd2871, 19629074.
-
(2009)
Nat Rev Drug Discov
, vol.8
, Issue.9
, pp. 709-723
-
-
Jänne, P.A.1
Gray, N.2
Settleman, J.3
-
4
-
-
0028232828
-
Expression of cytokeratin confers multiple drug resistance
-
7515497
-
Bauman PA, Dalton WS, Anderson JM, Cress AE. Expression of cytokeratin confers multiple drug resistance. Proc Nat Acad Sci USA 1994, 91(12):5311-4. 10.1073/pnas.91.12.5311, 7515497.
-
(1994)
Proc Nat Acad Sci USA
, vol.91
, Issue.12
, pp. 5311-5314
-
-
Bauman, P.A.1
Dalton, W.S.2
Anderson, J.M.3
Cress, A.E.4
-
6
-
-
84864402225
-
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
-
22751098
-
Zhang Z, Lee JC, Lin L, Olivas V, Au V, LaFramboise T, et al. Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer. Nat Genet 2012, 44(8):852-60. 10.1038/ng.2330, 22751098.
-
(2012)
Nat Genet
, vol.44
, Issue.8
, pp. 852-860
-
-
Zhang, Z.1
Lee, J.C.2
Lin, L.3
Olivas, V.4
Au, V.5
LaFramboise, T.6
-
7
-
-
84871998076
-
An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance
-
23091115
-
Byers LA, Diao L, Wang J, Saintigny P, Girard L, Peyton M, et al. An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin Cancer Res 2013, 19:279-90. 10.1158/1078-0432.CCR-12-1558, 23091115.
-
(2013)
Clin Cancer Res
, vol.19
, pp. 279-290
-
-
Byers, L.A.1
Diao, L.2
Wang, J.3
Saintigny, P.4
Girard, L.5
Peyton, M.6
-
8
-
-
84867760241
-
HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR-mutant lung cancers that lack the second-site EGFRT790M mutation
-
22956644
-
Takezawa K, Pirazzoli V, Arcila ME, Nebhan CA, Song X, et al. HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR-mutant lung cancers that lack the second-site EGFRT790M mutation. Cancer Discov 2012, 2(10):922-33. 10.1158/2159-8290.CD-12-0108, 22956644.
-
(2012)
Cancer Discov
, vol.2
, Issue.10
, pp. 922-933
-
-
Takezawa, K.1
Pirazzoli, V.2
Arcila, M.E.3
Nebhan, C.A.4
Song, X.5
-
9
-
-
34249075147
-
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
-
17463250
-
Engelman JA, Zejnullahu K, Mitsudomi T, Song Y, Hyland C, Park JO, et al. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 2007, 316(5827):1039-43. 10.1126/science.1141478, 17463250.
-
(2007)
Science
, vol.316
, Issue.5827
, pp. 1039-1043
-
-
Engelman, J.A.1
Zejnullahu, K.2
Mitsudomi, T.3
Song, Y.4
Hyland, C.5
Park, J.O.6
-
10
-
-
75149129568
-
Elevation of receptor tyrosine kinase EphA2 mediates resistance to trastuzumab therapy
-
20028874
-
Zhuang G, Brantley-Sieders DM, Vaught D, Yu J, Xie L, Wells S, et al. Elevation of receptor tyrosine kinase EphA2 mediates resistance to trastuzumab therapy. Cancer Res 2010, 70:299-308. 10.1158/0008-5472.CAN-09-1845, 20028874.
-
(2010)
Cancer Res
, vol.70
, pp. 299-308
-
-
Zhuang, G.1
Brantley-Sieders, D.M.2
Vaught, D.3
Yu, J.4
Xie, L.5
Wells, S.6
-
11
-
-
79958026380
-
The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
-
21531565
-
Mendoza MC, Er EE, Blenis J. The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. Trends Biochem Sci 2011, 36(6):320-8. 10.1016/j.tibs.2011.03.006, 21531565.
-
(2011)
Trends Biochem Sci
, vol.36
, Issue.6
, pp. 320-328
-
-
Mendoza, M.C.1
Er, E.E.2
Blenis, J.3
-
12
-
-
34948845576
-
Lapatinib in the treatment of breast cancer
-
17892419
-
Higa GM, Abraham J. Lapatinib in the treatment of breast cancer. Expert Rev Anticancer Ther 2007, 7(9):1183-92. 10.1586/14737140.7.9.1183, 17892419.
-
(2007)
Expert Rev Anticancer Ther
, vol.7
, Issue.9
, pp. 1183-1192
-
-
Higa, G.M.1
Abraham, J.2
-
13
-
-
51549083821
-
Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases
-
18803986
-
Medina PJ, Goodin S. Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases. Clin Ther 2008, 30(8):1426-47. 10.1016/j.clinthera.2008.08.008, 18803986.
-
(2008)
Clin Ther
, vol.30
, Issue.8
, pp. 1426-1447
-
-
Medina, P.J.1
Goodin, S.2
-
14
-
-
79953207364
-
Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase
-
21385943
-
Garrett JT, Olivares MG, Rinehart C, Granja-Ingram ND, Sanchez V, Chakrabarty A, et al. Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase. Proc Nat Acad Sci USA 2011, 108(12):5021-6. 10.1073/pnas.1016140108, 21385943.
-
(2011)
Proc Nat Acad Sci USA
, vol.108
, Issue.12
, pp. 5021-5026
-
-
Garrett, J.T.1
Olivares, M.G.2
Rinehart, C.3
Granja-Ingram, N.D.4
Sanchez, V.5
Chakrabarty, A.6
-
15
-
-
79953162369
-
Switching addictions between HER2 and FGFR2 in HER2-positive breast tumor cells: FGFR2 as a potential target for salvage after lapatinib failure
-
21377448
-
Azuma K, Tsurutani J, Sakai K, Kaneda H, Fujisaka Y, Takeda M, et al. Switching addictions between HER2 and FGFR2 in HER2-positive breast tumor cells: FGFR2 as a potential target for salvage after lapatinib failure. Biochem Biophys Res Commun 2011, 407:219-24. 10.1016/j.bbrc.2011.03.002, 21377448.
-
(2011)
Biochem Biophys Res Commun
, vol.407
, pp. 219-224
-
-
Azuma, K.1
Tsurutani, J.2
Sakai, K.3
Kaneda, H.4
Fujisaka, Y.5
Takeda, M.6
-
16
-
-
70149109569
-
Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL
-
19671800
-
Liu L, Greger J, Shi H, Liu Y, Greshock J, Annan R, et al. Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL. Cancer Res 2009, 69(17):6871-8. 10.1158/0008-5472.CAN-08-4490, 19671800.
-
(2009)
Cancer Res
, vol.69
, Issue.17
, pp. 6871-6878
-
-
Liu, L.1
Greger, J.2
Shi, H.3
Liu, Y.4
Greshock, J.5
Annan, R.6
-
17
-
-
84864200812
-
The glucose-deprivation network counteracts lapatinib-induced toxicity in resistant ErbB2-positive breast cancer cells.
-
Komurov K, Tseng JT, Muller M, Seviour EG, Moss TJ, Yang L, et al. The glucose-deprivation network counteracts lapatinib-induced toxicity in resistant ErbB2-positive breast cancer cells. Mol Syst Biol. 2012; 8(1)..
-
(2012)
Mol Syst Biol.
, vol.8
, Issue.1
-
-
Komurov, K.1
Tseng, J.T.2
Muller, M.3
Seviour, E.G.4
Moss, T.J.5
Yang, L.6
-
18
-
-
26844487041
-
Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor
-
16037379
-
Knowlden JM, Hutcheson IR, Barrow D, Gee JM, Nicholson RI. Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor. Endocrinology 2005, 146(11):4609-18. 10.1210/en.2005-0247, 16037379.
-
(2005)
Endocrinology
, vol.146
, Issue.11
, pp. 4609-4618
-
-
Knowlden, J.M.1
Hutcheson, I.R.2
Barrow, D.3
Gee, J.M.4
Nicholson, R.I.5
-
19
-
-
77649166990
-
Bayesian statistical modelling of human protein interaction network incorporating protein disorder information
-
20100321
-
Bulashevska S, Bulashevska A, Eils R. Bayesian statistical modelling of human protein interaction network incorporating protein disorder information. BMC Bioinformatics 2010, 11:46. 10.1186/1471-2105-11-46, 20100321.
-
(2010)
BMC Bioinformatics
, vol.11
, pp. 46
-
-
Bulashevska, S.1
Bulashevska, A.2
Eils, R.3
-
20
-
-
84868020742
-
Bayesian inference of signaling network topology in a cancer cell line
-
22923301
-
Hill SM, Lu Y, Molina J, Heiser LM, Spellman PT, Speed TP, et al. Bayesian inference of signaling network topology in a cancer cell line. Bioinformatics 2012, 28(21):2804-10. 10.1093/bioinformatics/bts514, 22923301.
-
(2012)
Bioinformatics
, vol.28
, Issue.21
, pp. 2804-2810
-
-
Hill, S.M.1
Lu, Y.2
Molina, J.3
Heiser, L.M.4
Spellman, P.T.5
Speed, T.P.6
-
21
-
-
84860851412
-
Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks
-
22579283
-
Lee MJ, Ye AS, Gardino AK, Heijink AM, Sorger PK, MacBeath G, et al. Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks. Cell 2012, 149(4):780-94. 10.1016/j.cell.2012.03.031, 22579283.
-
(2012)
Cell
, vol.149
, Issue.4
, pp. 780-794
-
-
Lee, M.J.1
Ye, A.S.2
Gardino, A.K.3
Heijink, A.M.4
Sorger, P.K.5
MacBeath, G.6
-
22
-
-
33847285870
-
Oncogenic re-wiring of cellular signaling pathways
-
17322911
-
Pawson T, Warner N. Oncogenic re-wiring of cellular signaling pathways. Oncogene 2007, 26(9):1268-75. 10.1038/sj.onc.1210255, 17322911.
-
(2007)
Oncogene
, vol.26
, Issue.9
, pp. 1268-1275
-
-
Pawson, T.1
Warner, N.2
-
23
-
-
1542515338
-
A census of human cancer genes
-
14993899
-
Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, et al. A census of human cancer genes. Nat Rev Cancer 2004, 4(3):177-83. 10.1038/nrc1299, 14993899.
-
(2004)
Nat Rev Cancer
, vol.4
, Issue.3
, pp. 177-183
-
-
Futreal, P.A.1
Coin, L.2
Marshall, M.3
Down, T.4
Hubbard, T.5
Wooster, R.6
-
24
-
-
84950607156
-
An exponential family of probability distributions for directed graphs
-
Holland PW, Leinhardt S. An exponential family of probability distributions for directed graphs. J Am Stat Assoc 1981, 76(373):33-50. 10.1080/01621459.1981.10477598.
-
(1981)
J Am Stat Assoc
, vol.76
, Issue.373
, pp. 33-50
-
-
Holland, P.W.1
Leinhardt, S.2
-
25
-
-
0011376709
-
A proposed index of the conformity of one sociometric measurement to another
-
Katz L, Powell J. A proposed index of the conformity of one sociometric measurement to another. Psychometrika 1953, 18(3):249-56. 10.1007/BF02289063.
-
(1953)
Psychometrika
, vol.18
, Issue.3
, pp. 249-256
-
-
Katz, L.1
Powell, J.2
-
26
-
-
0030491229
-
Logit models and logistic regressions for social networks: I. An introduction to Markov graphs andp
-
Wasserman S, Pattison P. Logit models and logistic regressions for social networks: I. An introduction to Markov graphs andp. Psychometrika 1996, 61(3):401-25. 10.1007/BF02294547.
-
(1996)
Psychometrika
, vol.61
, Issue.3
, pp. 401-425
-
-
Wasserman, S.1
Pattison, P.2
-
27
-
-
0001399123
-
Pseudolikelihood estimation for social networks
-
Strauss D, Ikeda M. Pseudolikelihood estimation for social networks. J Am Stat Assoc 1990, 85(409):204-12. 10.1080/01621459.1990.10475327.
-
(1990)
J Am Stat Assoc
, vol.85
, Issue.409
, pp. 204-212
-
-
Strauss, D.1
Ikeda, M.2
-
28
-
-
0003314308
-
Markov chain monte carlo estimation of exponential random graph models.
-
Snijders TAB. Markov chain monte carlo estimation of exponential random graph models. J Soc Struct. 2002; 3(2)..
-
(2002)
J Soc Struct.
, vol.3
, Issue.2
-
-
Snijders, T.A.B.1
-
29
-
-
0006407254
-
WinBUGS - A Bayesian modelling framework: concepts, structure, and extensibility
-
Lunn DJ, Thomas A, Best N, Spiegelhalter D. WinBUGS - A Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput 2000, 10(4):325-37. [http://dx.doi.org/10.1023/A:1008929526011]., 10.1023/A:1008929526011.
-
(2000)
Stat Comput
, vol.10
, Issue.4
, pp. 325-337
-
-
Lunn, D.J.1
Thomas, A.2
Best, N.3
Spiegelhalter, D.4
-
31
-
-
45449101889
-
A global pathway crosstalk network
-
18434343
-
Li Y, Agarwal P, Rajagopalan D. A global pathway crosstalk network. Bioinformatics 2008, 24(12):1442-7. 10.1093/bioinformatics/btn200, 18434343.
-
(2008)
Bioinformatics
, vol.24
, Issue.12
, pp. 1442-1447
-
-
Li, Y.1
Agarwal, P.2
Rajagopalan, D.3
-
32
-
-
84891753483
-
The Reactome pathway knowledgebase
-
24243840
-
Croft D, Mundo AF, Haw R, Milacic M, Weiser J, Wu G, et al. The Reactome pathway knowledgebase. Nucleic Acids Res 2014, 42(D1):D472-7. 10.1093/nar/gkt1102, 24243840.
-
(2014)
Nucleic Acids Res
, vol.42
, Issue.D1
, pp. D472-D477
-
-
Croft, D.1
Mundo, A.F.2
Haw, R.3
Milacic, M.4
Weiser, J.5
Wu, G.6
-
33
-
-
0037805576
-
The KEGG database
-
12539951
-
Kanehisa M. The KEGG database. Novartis Found Symp 2002, 247:91-101. 10.1002/0470857897.ch8, 12539951.
-
(2002)
Novartis Found Symp
, vol.247
, pp. 91-101
-
-
Kanehisa, M.1
-
35
-
-
84862203775
-
WikiPathways: building research communities on biological pathways
-
22096230
-
Kelder T, van Iersel MP, Hanspers K, Kutmon M, Conklin BR, et al. WikiPathways: building research communities on biological pathways. Nucleic Acids Res 2012, 40(Database issue):D1301-7. 10.1093/nar/gkr1074, 22096230.
-
(2012)
Nucleic Acids Res
, vol.40
, Issue.Database issue
, pp. D1301-D1307
-
-
Kelder, T.1
van Iersel, M.P.2
Hanspers, K.3
Kutmon, M.4
Conklin, B.R.5
-
36
-
-
84862630475
-
NetWalker: a contextual network analysis tool for functional genomics
-
22732065
-
Komurov K, Dursun S, Erdin S, Ram P. NetWalker: a contextual network analysis tool for functional genomics. BMC Genomics 2012, 13:282. 10.1186/1471-2164-13-282, 22732065.
-
(2012)
BMC Genomics
, vol.13
, pp. 282
-
-
Komurov, K.1
Dursun, S.2
Erdin, S.3
Ram, P.4
-
37
-
-
84880306937
-
The Notch signaling pathway as a mediator of tumor survival
-
23585460
-
Capaccione KM, Pine SR. The Notch signaling pathway as a mediator of tumor survival. Carcinogenesis 2013, 34(7):1420-30. 10.1093/carcin/bgt127, 23585460.
-
(2013)
Carcinogenesis
, vol.34
, Issue.7
, pp. 1420-1430
-
-
Capaccione, K.M.1
Pine, S.R.2
-
38
-
-
33646257783
-
Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression
-
16618740
-
Liu ZJ, Xiao M, Balint K, Smalley KS, Brafford P, Qiu R, et al. Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression. Cancer Res 2006, 66(8):4182-90. 10.1158/0008-5472.CAN-05-3589, 16618740.
-
(2006)
Cancer Res
, vol.66
, Issue.8
, pp. 4182-4190
-
-
Liu, Z.J.1
Xiao, M.2
Balint, K.3
Smalley, K.S.4
Brafford, P.5
Qiu, R.6
-
39
-
-
0029085935
-
Signalling downstream of activated mammalian Notch
-
7566092
-
Jarriault S, Brou C, Logeat F, Schroeter EH, Kopan R, Israel A. Signalling downstream of activated mammalian Notch. Nature 1995, 377(6547):355-8. 10.1038/377355a0, 7566092.
-
(1995)
Nature
, vol.377
, Issue.6547
, pp. 355-358
-
-
Jarriault, S.1
Brou, C.2
Logeat, F.3
Schroeter, E.H.4
Kopan, R.5
Israel, A.6
-
40
-
-
34948908663
-
Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia
-
17873882
-
Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K, Ciofani M, et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 2007, 13(10):1203-10. 10.1038/nm1636, 17873882.
-
(2007)
Nat Med
, vol.13
, Issue.10
, pp. 1203-1210
-
-
Palomero, T.1
Sulis, M.L.2
Cortina, M.3
Real, P.J.4
Barnes, K.5
Ciofani, M.6
-
41
-
-
33845306813
-
NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth
-
17114293
-
Palomero T, Lim WK, Odom DT, Sulis ML, Real PJ, Margolin A, et al. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Nat Acad Sci USA 2006, 103(48):18261-6. 10.1073/pnas.0606108103, 17114293.
-
(2006)
Proc Nat Acad Sci USA
, vol.103
, Issue.48
, pp. 18261-18266
-
-
Palomero, T.1
Lim, W.K.2
Odom, D.T.3
Sulis, M.L.4
Real, P.J.5
Margolin, A.6
-
42
-
-
33746546368
-
C-Myc is an important direct target of Notch1 in T-cell lymphoblastic leukemia/lymphoma
-
16847353
-
Weng AP, Millholland JM, Yashiro-Ohtani Y, Arcangeli ML, Lau A, Wai C, et al. c-Myc is an important direct target of Notch1 in T-cell lymphoblastic leukemia/lymphoma. Genes Dev 2006, 20(15):2096-109. 10.1101/gad.1450406, 16847353.
-
(2006)
Genes Dev
, vol.20
, Issue.15
, pp. 2096-2109
-
-
Weng, A.P.1
Millholland, J.M.2
Yashiro-Ohtani, Y.3
Arcangeli, M.L.4
Lau, A.5
Wai, C.6
-
43
-
-
0343517577
-
Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2
-
10644343
-
Strobl LJ, Hofelmayr H, Marschall G, Brielmeier M, Bornkamm GW, Zimber-Strobl U. Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2. J Virol 2000, 74(4):1727-35. 10.1128/JVI.74.4.1727-1735.2000, 10644343.
-
(2000)
J Virol
, vol.74
, Issue.4
, pp. 1727-1735
-
-
Strobl, L.J.1
Hofelmayr, H.2
Marschall, G.3
Brielmeier, M.4
Bornkamm, G.W.5
Zimber-Strobl, U.6
-
44
-
-
0035736487
-
HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation
-
11715018
-
Zhou BP, Liao Y, Xia W, Zou Y, Spohn B, Hung MC. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat Cell Biol 2001, 3(11):973-82. 10.1038/ncb1101-973, 11715018.
-
(2001)
Nat Cell Biol
, vol.3
, Issue.11
, pp. 973-982
-
-
Zhou, B.P.1
Liao, Y.2
Xia, W.3
Zou, Y.4
Spohn, B.5
Hung, M.C.6
-
45
-
-
17844379782
-
TRAIL is a key target in S-phase slowing-dependent apoptosis induced by interferon-beta in cervical carcinoma cells
-
15735750
-
Vannucchi S, Chiantore MV, Fiorucci G, Percario ZA, Leone S, Affabris E, et al. TRAIL is a key target in S-phase slowing-dependent apoptosis induced by interferon-beta in cervical carcinoma cells. Oncogene 2005, 24(15):2536-46. 10.1038/sj.onc.1208403, 15735750.
-
(2005)
Oncogene
, vol.24
, Issue.15
, pp. 2536-2546
-
-
Vannucchi, S.1
Chiantore, M.V.2
Fiorucci, G.3
Percario, Z.A.4
Leone, S.5
Affabris, E.6
-
46
-
-
22244486994
-
The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53
-
16023600
-
Higashitsuji H, Higashitsuji H, Itoh K, Sakurai T, Nagao T, et al. The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53. Cancer Cell 2005, 8:75-87. 10.1016/j.ccr.2005.06.006, 16023600.
-
(2005)
Cancer Cell
, vol.8
, pp. 75-87
-
-
Higashitsuji, H.1
Higashitsuji, H.2
Itoh, K.3
Sakurai, T.4
Nagao, T.5
-
47
-
-
84860491093
-
Role of Wnt/beta-catenin signaling in drug resistance of pancreatic cancer
-
22372504
-
Cui J, Jiang W, Wang S, Wang L, Xie K. Role of Wnt/beta-catenin signaling in drug resistance of pancreatic cancer. Curr Pharm Des 2012, 18(17):2464-71. 10.2174/13816128112092464, 22372504.
-
(2012)
Curr Pharm Des
, vol.18
, Issue.17
, pp. 2464-2471
-
-
Cui, J.1
Jiang, W.2
Wang, S.3
Wang, L.4
Xie, K.5
-
48
-
-
19944403876
-
Wnt/β-catenin signaling pathway as a novel cancer drug target
-
15578921
-
Luu HH, Zhang R, Haydon RC, Rayburn E, Kang Q, Si W, et al. Wnt/β-catenin signaling pathway as a novel cancer drug target. Curr Cancer Drug Targets 2004, 4(8):653-71. 10.2174/1568009043332709, 15578921.
-
(2004)
Curr Cancer Drug Targets
, vol.4
, Issue.8
, pp. 653-671
-
-
Luu, H.H.1
Zhang, R.2
Haydon, R.C.3
Rayburn, E.4
Kang, Q.5
Si, W.6
-
49
-
-
84875505291
-
The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer
-
23547709
-
Loh YN, Hedditch EL, Baker LA, Jary E, Ward RL, Ford CE. The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer. BMC Cancer 2013, 13:174. 10.1186/1471-2407-13-174, 23547709.
-
(2013)
BMC Cancer
, vol.13
, pp. 174
-
-
Loh, Y.N.1
Hedditch, E.L.2
Baker, L.A.3
Jary, E.4
Ward, R.L.5
Ford, C.E.6
-
50
-
-
77955078486
-
Inhibition of Wnt signaling pathway decreases chemotherapyresistant side-population colon cancer cells
-
20651349
-
Chikazawa N, Tanaka H, Tasaka T, Nakamura M, Tanaka M, et al. Inhibition of Wnt signaling pathway decreases chemotherapyresistant side-population colon cancer cells. Anticancer Res 2010, 30(6):2041-8. 20651349.
-
(2010)
Anticancer Res
, vol.30
, Issue.6
, pp. 2041-2048
-
-
Chikazawa, N.1
Tanaka, H.2
Tasaka, T.3
Nakamura, M.4
Tanaka, M.5
-
51
-
-
84863384604
-
NKX2-1/TITF1/TTF-1-Induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinoma
-
22439932
-
Yamaguchi T, Yanagisawa K, Sugiyama R, Hosono Y, Shimada Y, Arima C, et al. NKX2-1/TITF1/TTF-1-Induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinoma. Cancer Cell 2012, 21(3):348-61. 10.1016/j.ccr.2012.02.008, 22439932.
-
(2012)
Cancer Cell
, vol.21
, Issue.3
, pp. 348-361
-
-
Yamaguchi, T.1
Yanagisawa, K.2
Sugiyama, R.3
Hosono, Y.4
Shimada, Y.5
Arima, C.6
-
52
-
-
75349109588
-
Nuclear APC
-
19928349
-
Neufeld KL. Nuclear APC. Adv Exp Med Biol 2009, 656:13-29. 10.1007/978-1-4419-1145-2_2, 19928349.
-
(2009)
Adv Exp Med Biol
, vol.656
, pp. 13-29
-
-
Neufeld, K.L.1
-
53
-
-
0038412776
-
Stimulation of human DNA polymerase epsilon by MDM2
-
12711691
-
Asahara H, Li Y, Fuss J, Haines DS, Vlatkovic N, Boyd MT, et al. Stimulation of human DNA polymerase epsilon by MDM2. Nucleic Acids Res 2003, 31(9):2451-9. 10.1093/nar/gkg342, 12711691.
-
(2003)
Nucleic Acids Res
, vol.31
, Issue.9
, pp. 2451-2459
-
-
Asahara, H.1
Li, Y.2
Fuss, J.3
Haines, D.S.4
Vlatkovic, N.5
Boyd, M.T.6
-
54
-
-
0023841872
-
Elevated DNA polymerase beta activity in a cis-diamminedichloroplatinum(II) resistant P388 murine leukemia cell line
-
3349449
-
Kraker AJ, Moore CW. Elevated DNA polymerase beta activity in a cis-diamminedichloroplatinum(II) resistant P388 murine leukemia cell line. Cancer Lett 1988, 38(3):307-14. 10.1016/0304-3835(88)90022-5, 3349449.
-
(1988)
Cancer Lett
, vol.38
, Issue.3
, pp. 307-314
-
-
Kraker, A.J.1
Moore, C.W.2
-
55
-
-
84871846692
-
WNT signalling pathways as therapeutic targets in cancer
-
Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer 2012, 13:11-26. [http://dx.doi.org/10.1038/nrc3419]., 10.1038/nrc3419.
-
(2012)
Nat Rev Cancer
, vol.13
, pp. 11-26
-
-
Anastas, J.N.1
Moon, R.T.2
-
56
-
-
84862013453
-
β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer
-
22610277
-
Tenbaum SP, Ordonez-Moran P, Puig I, Chicote I, Arques O, Landolfi S, et al. β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer. Nat Med 2012, 18(6):892-901. 10.1038/nm.2772, 22610277.
-
(2012)
Nat Med
, vol.18
, Issue.6
, pp. 892-901
-
-
Tenbaum, S.P.1
Ordonez-Moran, P.2
Puig, I.3
Chicote, I.4
Arques, O.5
Landolfi, S.6
-
57
-
-
84892171530
-
GPCR-like signaling mediated by smoothened contributes to acquired chemoresistance through activating Gli
-
24393163
-
Zhan X, Wang J, Liu Y, Peng Y, Tan W. GPCR-like signaling mediated by smoothened contributes to acquired chemoresistance through activating Gli. Mol Cancer 2014, 13:4. 10.1186/1476-4598-13-4, 24393163.
-
(2014)
Mol Cancer
, vol.13
, pp. 4
-
-
Zhan, X.1
Wang, J.2
Liu, Y.3
Peng, Y.4
Tan, W.5
-
58
-
-
34248327024
-
Making BUGS Open
-
Thomas A, OHara B, Ligges U, Sturtz S. Making BUGS Open. R News 2006, 6:12-7.
-
(2006)
R News
, vol.6
, pp. 12-17
-
-
Thomas, A.1
OHara, B.2
Ligges, U.3
Sturtz, S.4
-
59
-
-
42449109533
-
Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2
-
18359851
-
Abe Y, Oda-Sato E, Tobiume K, Kawauchi K, Taya Y, Okamoto K, et al. Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2. Proc Nat Acad Sci USA 2008, 105(12):4838-43. 10.1073/pnas.0712216105, 18359851.
-
(2008)
Proc Nat Acad Sci USA
, vol.105
, Issue.12
, pp. 4838-4843
-
-
Abe, Y.1
Oda-Sato, E.2
Tobiume, K.3
Kawauchi, K.4
Taya, Y.5
Okamoto, K.6
-
60
-
-
77952546990
-
Evaluating Smoothened as a G-protein-coupled receptor for Hedgehog signalling
-
20207148
-
Ayers KL, Therond PP. Evaluating Smoothened as a G-protein-coupled receptor for Hedgehog signalling. Trends Cell Biol 2010, 20(5):287-98. 10.1016/j.tcb.2010.02.002, 20207148.
-
(2010)
Trends Cell Biol
, vol.20
, Issue.5
, pp. 287-298
-
-
Ayers, K.L.1
Therond, P.P.2
-
61
-
-
59349106501
-
Hedgehog signaling: is Smo a G protein-coupled receptor?
-
19211052
-
Philipp M, Caron MG. Hedgehog signaling: is Smo a G protein-coupled receptor?. Curr Biol 2009, 19(3):R125-7. 10.1016/j.cub.2008.12.010, 19211052.
-
(2009)
Curr Biol
, vol.19
, Issue.3
, pp. R125-R127
-
-
Philipp, M.1
Caron, M.G.2
-
62
-
-
70349148288
-
Crosstalk between epidermal growth factor receptor- and insulin-like growth factor-1 receptor signaling: implications for cancer therapy
-
19754359
-
van der Veeken J, Oliveira S, Schiffelers RM, Storm G, van Bergen En Henegouwen PM, Roovers RC. Crosstalk between epidermal growth factor receptor- and insulin-like growth factor-1 receptor signaling: implications for cancer therapy. Curr Cancer Drug Targets 2009, 9(6):748-60. 10.2174/156800909789271495, 19754359.
-
(2009)
Curr Cancer Drug Targets
, vol.9
, Issue.6
, pp. 748-760
-
-
van der Veeken, J.1
Oliveira, S.2
Schiffelers, R.M.3
Storm, G.4
Van Bergen En Henegouwen, P.M.5
Roovers, R.C.6
-
63
-
-
84864006046
-
Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfalls
-
22423264
-
Fidler MJ, Shersher DD, Borgia JA, Bonomi P. Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfalls. Ther Adv Med Oncol 2012, 4(2):51-60. 10.1177/1758834011427576, 22423264.
-
(2012)
Ther Adv Med Oncol
, vol.4
, Issue.2
, pp. 51-60
-
-
Fidler, M.J.1
Shersher, D.D.2
Borgia, J.A.3
Bonomi, P.4
-
64
-
-
84881490675
-
Inhibition of both EGFR and IGF1R sensitized prostate cancer cells to radiation by synergistic suppression of DNA homologous recombination repair
-
23950876
-
Wang Y, Yuan JL, Zhang YT, Ma JJ, Xu P, Shi CH, et al. Inhibition of both EGFR and IGF1R sensitized prostate cancer cells to radiation by synergistic suppression of DNA homologous recombination repair. PLoS ONE 2013, 8(8):e68784. 10.1371/journal.pone.0068784, 23950876.
-
(2013)
PLoS ONE
, vol.8
, Issue.8
-
-
Wang, Y.1
Yuan, J.L.2
Zhang, Y.T.3
Ma, J.J.4
Xu, P.5
Shi, C.H.6
-
65
-
-
65549158055
-
High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients
-
19153117
-
Ludovini V, Bellezza G, Pistola L, Bianconi F, Di Carlo L, Sidoni A, et al. High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients. Ann Oncol 2009, 20(5):842-9. 10.1093/annonc/mdn727, 19153117.
-
(2009)
Ann Oncol
, vol.20
, Issue.5
, pp. 842-849
-
-
Ludovini, V.1
Bellezza, G.2
Pistola, L.3
Bianconi, F.4
Di Carlo, L.5
Sidoni, A.6
-
66
-
-
47549108868
-
Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib ('Iressa') response and resistance
-
17902048
-
Knowlden JM, Jones HE, Barrow D, Gee JM, Nicholson RI, Hutcheson IR. Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib ('Iressa') response and resistance. Breast Cancer Res Treat 2008, 111:79-91. 10.1007/s10549-007-9763-9, 17902048.
-
(2008)
Breast Cancer Res Treat
, vol.111
, pp. 79-91
-
-
Knowlden, J.M.1
Jones, H.E.2
Barrow, D.3
Gee, J.M.4
Nicholson, R.I.5
Hutcheson, I.R.6
-
67
-
-
32044435126
-
Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways
-
16452501
-
Levine AJ, Feng Z, Mak TW, You H, Jin S. Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways. Genes Dev 2006, 20(3):267-75. 10.1101/gad.1363206, 16452501.
-
(2006)
Genes Dev
, vol.20
, Issue.3
, pp. 267-275
-
-
Levine, A.J.1
Feng, Z.2
Mak, T.W.3
You, H.4
Jin, S.5
-
68
-
-
84881116878
-
Voting-based cancer module identification by combining topological and data-driven properties
-
23940583
-
Azad AK, Lee H. Voting-based cancer module identification by combining topological and data-driven properties. PLoS ONE 2013, 8(8):e70498. 10.1371/journal.pone.0070498, 23940583.
-
(2013)
PLoS ONE
, vol.8
, Issue.8
-
-
Azad, A.K.1
Lee, H.2
|